Curi RMB Capital’s BioLife Solutions BLFS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.66M | Buy |
448,358
+9,673
| +2% | +$208K | 0.18% | 145 |
|
|
2025
Q1 | $10M | Buy |
438,685
+4,870
| +1% | +$111K | 0.25% | 118 |
|
|
2024
Q4 | $11.3M | Buy |
433,815
+11,882
| +3% | +$308K | 0.26% | 122 |
|
|
2024
Q3 | $10.6M | Buy |
421,933
+2,283
| +0.5% | +$57.2K | 0.24% | 127 |
|
|
2024
Q2 | $8.99M | Sell |
419,650
-1,576
| -0.4% | -$33.8K | 0.22% | 137 |
|
|
2024
Q1 | $7.81M | Buy |
421,226
+22,455
| +6% | +$417K | 0.18% | 152 |
|
|
2023
Q4 | $6.48M | Sell |
398,771
-713
| -0.2% | -$11.6K | 0.2% | 131 |
|
|
2023
Q3 | $5.52M | Buy |
399,484
+45,394
| +13% | +$627K | 0.19% | 131 |
|
|
2023
Q2 | $7.83M | Buy |
354,090
+7,628
| +2% | +$169K | 0.26% | 108 |
|
|
2023
Q1 | $7.54M | Buy |
346,462
+15,485
| +5% | +$337K | 0.26% | 108 |
|
|
2022
Q4 | $6.02M | Sell |
330,977
-12,966
| -4% | -$236K | 0.21% | 124 |
|
|
2022
Q3 | $7.83M | Sell |
343,943
-7,023
| -2% | -$160K | 0.29% | 100 |
|
|
2022
Q2 | $4.85M | Buy |
350,966
+25,986
| +8% | +$359K | 0.17% | 134 |
|
|
2022
Q1 | $7.39M | Buy |
324,980
+38,643
| +13% | +$878K | 0.23% | 111 |
|
|
2021
Q4 | $10.7M | Buy |
286,337
+8,005
| +3% | +$298K | 0.32% | 86 |
|
|
2021
Q3 | $11.8M | Sell |
278,332
-5,247
| -2% | -$222K | 0.39% | 79 |
|
|
2021
Q2 | $12.6M | Buy |
283,579
+89,677
| +46% | +$3.99M | 0.42% | 72 |
|
|
2021
Q1 | $6.98M | Buy |
+193,902
| New | +$6.98M | 0.26% | 105 |
|